Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) have received a consensus rating of “Buy” from the nine brokerages that are currently covering the firm, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold recommendation, five have issued a buy recommendation and one has assigned a strong buy recommendation to […]
Brokerages predict that United Therapeutics Co. (NASDAQ:UTHR – Get Rating) will report earnings per share (EPS) of $2.95 for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for United Therapeutics’ earnings. The lowest EPS estimate is $2.27 and the highest is $3.30. United Therapeutics posted earnings of $0.61 per share during […]
GW Henssler & Associates Ltd. acquired a new position in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) in the fourth quarter, Holdings Channel.com reports. The institutional investor acquired 3,315 shares of the biotechnology company’s stock, valued at approximately $716,000. A number of other large investors have also modified their holdings of the stock. Deutsche Bank […]
United Therapeutics Co. (NASDAQ:UTHR – Get Rating) – Jefferies Financial Group boosted their Q1 2022 earnings estimates for shares of United Therapeutics in a report issued on Monday, March 28th. Jefferies Financial Group analyst E. Yang now expects that the biotechnology company will post earnings per share of $3.27 for the quarter, up from their […]
StockNews.com downgraded shares of United Therapeutics (NASDAQ:UTHR – Get Rating) from a strong-buy rating to a buy rating in a research report released on Thursday. Other analysts also recently issued research reports about the company. LADENBURG THALM/SH SH dropped their price target on United Therapeutics from $231.00 to $203.00 and set a buy rating for […]